$14.53 0.3%
PGNY Stock Price vs. AI Score
Data gathered: December 24

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Progyny (PGNY)

Analysis generated July 8, 2024. Powered by Chat GPT.

Progyny, Inc. is a leading benefits management company specializing in fertility and family building benefits solutions in the United States. The firm partners with employers to provide a comprehensive fertility benefits program through its network of specialized providers. As the fertility market continues to grow, Progyny's integrated approach and customizable solutions help it stand out in an increasingly competitive field.

Read full AI stock Analysis

Stock Alerts - Progyny (PGNY)

company logo Progyny | December 10
Web Traffic is down by 31.2% over the last month.
company logo Progyny | December 9
Price is up by 5% in the last 24h.
company logo Progyny | December 5
Over the past few months, there has been a noticeable upward trend in Instagram Followers.
company logo Progyny | December 3
Employee Rating is up by 3.5% over the last month.

About Progyny

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States.


Progyny
Price $14.53
Target Price Sign up
Volume 225,560
Market Cap $1.22B
Year Range $13.67 - $33.06
Dividend Yield 0%
PE Ratio 23.9
Analyst Rating 36% buy
Industry Health Care Services

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24287M274M59M10M00.400
Q2 '24304M283M68M16M21M0.170
Q1 '24279M260M62M17M19M0.170
Q4 '23271M256M57M13M14M0.130
Q3 '23282M263M63M16M19M0.160

Insider Transactions View All

Payson Norman filed to sell 580,656 shares at $56.3.
November 26 '21
Sturmer Michael E filed to sell 362,583 shares at $30.
July 18 '24
Scott Cheryl filed to sell 10,098 shares at $28.4.
July 1 '24
Sturmer Michael E filed to sell 380,038 shares at $32.
May 2 '24
Livingston Mark S. filed to sell 59,155 shares at $37.6.
April 3 '24

What is the Market Cap of Progyny?

The Market Cap of Progyny is $1.22B.

What is Progyny's PE Ratio?

As of today, Progyny's PE (Price to Earnings) ratio is 23.9.

What is the current stock price of Progyny?

Currently, the price of one share of Progyny stock is $14.53.

How can I analyze the PGNY stock price chart for investment decisions?

The PGNY stock price chart above provides a comprehensive visual representation of Progyny's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Progyny shares. Our platform offers an up-to-date PGNY stock price chart, along with technical data analysis and alternative data insights.

Does PGNY offer dividends to its shareholders?

As of our latest update, Progyny (PGNY) does not offer dividends to its shareholders. Investors interested in Progyny should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Progyny?

Some of the similar stocks of Progyny are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.